| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9404 | 
      | Human Intestinal Absorption | HIA+ | 1.0000 | 
      | Caco-2 Permeability | Caco2+ | 0.5435 | 
      | P-glycoprotein Substrate | Non-substrate | 0.8662 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.8868 | 
                                                     | Non-inhibitor | 0.7851 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8682 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.5237 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.6230 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8734 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.7251 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.8950 | 
      | CYP450 2C9 Inhibitor | Inhibitor | 0.8354 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9402 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.8993 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.7191 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6403 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9480 | 
                                                                    | Non-inhibitor | 0.8154 | 
      | AMES Toxicity | Non AMES toxic | 0.7932 | 
      | Carcinogens | Non-carcinogens | 0.8285 | 
      | Fish Toxicity | High FHMT | 0.9688 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.7223 | 
      | Honey Bee Toxicity | Low HBT | 0.8869 | 
      | Biodegradation | Not ready biodegradable | 0.9950 | 
      | Acute Oral Toxicity | III | 0.6841 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5754 |